TTOO Projected Dividend Yield
T2 Biosystems Inc ( NASDAQ : TTOO )T2 Biosystems is an in vitro diagnostics company and engaged in the detection of sepsis-causing pathogens and antibiotic resistance genes. Co.'s products include: T2Dx® Instrument, which runs diagnostic tests from patient samples; T2Candida® Panel, which is a direct-from-blood test that identifies the lethal form of blood stream infections that cause sepsis candidemia; T2Bacteria® Panel, which is a direct-from-blood test that detects bacterial pathogens associated with sepsis; T2Resistance® Panel, which is a direct-from-blood test that detects resistance genes from both gram-positive and gram-negative pathogens; and T2SARS-CoV-2™ Panel, which detect SARS-CoV-2, the coronavirus in patients. 20 YEAR PERFORMANCE RESULTS |
TTOO Dividend History Detail TTOO Dividend News TTOO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |